Nanotemplate Engineering

Nanotemplate Engineering is a scalable, nanoparticle manufacturing technology used to formulate small molecules, peptides, proteins, plasmid DNA, and diagnostic agents. Nanotemplate Engineering technology has been the subject of more than 40 peer-reviewed scientific publications authored by NanoMed’s co-founders, Russell J. Mumper, Ph.D. and Michael Jay, Ph.D. NanoMed has the exclusive rights to U.S. Patent 7,153,525 (“Microemulsions As Precursors To Solid Nanoparticles”) which covers processes and applications of Nanotemplate Engineering.